Marvin Martens
Marvin Martens
PhD Candidate, Maastricht University
Dirección de correo verificada de
Citado por
Citado por
WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research
DN Slenter, M Kutmon, K Hanspers, A Riutta, J Windsor, N Nunes, ...
Nucleic acids research 46 (D1), D661-D667, 2018
Adverse outcome pathways: opportunities, limitations and open questions
M Leist, A Ghallab, R Graepel, R Marchan, R Hassan, SH Bennekou, ...
Archives of toxicology 91 (11), 3477-3505, 2017
WikiPathways: connecting communities
M Martens, A Ammar, A Riutta, A Waagmeester, DN Slenter, K Hanspers, ...
Nucleic acids research 49 (D1), D613-D621, 2021
COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms
M Ostaszewski, A Niarakis, A Mazein, I Kuperstein, R Phair, ...
Molecular systems biology 17 (10), e10387, 2021
Introducing WikiPathways as a data-source to support adverse outcome pathways for regulatory risk assessment of chemicals and nanomaterials
M Martens, T Verbruggen, P Nymark, R Grafström, LD Burgoon, H Aladjov, ...
Frontiers in Genetics 9, 661, 2018
Genome-wide strategies identify downstream target genes of chick connective tissue-associated transcription factors
M Orgeur, M Martens, G Leonte, S Nassari, MA Bonnin, ST Börno, ...
Development 145 (7), dev161208, 2018
Intratumoral combination therapy with poly (I: C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity
C Anfray, F Mainini, E Digifico, A Maeda, M Sironi, M Erreni, A Anselmo, ...
Journal for immunotherapy of cancer 9 (9), 2021
A dual transcript-discovery approach to improve the delimitation of gene features from RNA-seq data in the chicken model
M Orgeur, M Martens, ST Börno, B Timmermann, D Duprez, S Stricker
Biology Open 7 (1), bio028498, 2018
Metabolism and toxicity of fluorine compounds
JL Kyzer, M Martens
Chemical Research in Toxicology 34 (3), 678-680, 2021
A strategy towards the generation of testable adverse outcome pathways for nanomaterials
S Murugadoss, IV Vrcek, B Pem, K Jagiello, B Judzinska, A Sosnowska, ...
ALTEX-Alternatives to animal experimentation 38 (4), 580-594, 2021
COVID-19 through adverse outcome pathways: Building networks to better understand the disease–3rd CIAO AOP Design Workshop
LA Clerbaux, N Amigó, MJ Amorim, A Bal-Price, SB Leite, A Beronius, ...
ALTEX-Alternatives to animal experimentation 39 (2), 322-335, 2022
Towards a qAOP framework for predictive toxicology-Linking data to decisions
A Paini, I Campia, MTD Cronin, D Asturiol, L Ceriani, TE Exner, W Gao, ...
Computational Toxicology 21, 100195, 2022
Providing Adverse Outcome Pathways from the AOP-Wiki in a Semantic Web Format to Increase Usability and Accessibility of the Content
M Martens, CT Evelo, EL Willighagen
Applied in vitro toxicology 8 (1), 2-13, 2022
Ten simple rules for creating reusable pathway models for computational analysis and visualization
K Hanspers, M Kutmon, SL Coort, D Digles, LJ Dupuis, F Ehrhart, F Hu, ...
PLoS Computational Biology 17 (8), e1009226, 2021
BridgeDb and Wikidata: a powerful combination generating interoperable open research (BridgeDb)
E Willighagen, M Kutmon, M Martens, D Slenter
Research Ideas and Outcomes 8, e83031, 2022
A Community-Driven, Openly Accessible Molecular Pathway Integrating Knowledge on Malignant Pleural Mesothelioma
M Martens, F Kreidl, F Ehrhart, D Jean, M Mei, HM Mortensen, A Nash, ...
Frontiers in oncology 12, 2022
The AOP-DB RDF: Applying FAIR Principles to the Semantic Integration of AOP Data Using the Research Description Framework
HM Mortensen, M Martens, J Senn, T Levey, CT Evelo, EL Willighagen, ...
Frontiers in Toxicology 4, 2022
ELIXIR and Toxicology: a community in development
M Martens, R Stierum, EL Schymanski, CT Evelo, R Aalizadeh, H Aladjov, ...
F1000Research 10 (1129), 1129, 2021
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–18